Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders

被引:2
|
作者
Nelson, Jonas A. [1 ,2 ]
McKernan, Cayla D. [1 ]
Rubenstein, Robyn N. [1 ]
Shamsunder, Meghana G. [1 ]
Poulton, Ricky [1 ]
Dabic, Stefan [1 ]
Mehrara, Babak J. [1 ]
Disa, Joseph J. [1 ]
Cordeiro, Peter G. [1 ]
McCarthy, Colleen M. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Plast & Reconstruct Surg Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Plast & Reconstruct Surg Serv, 321 East 61st St, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
LONG-TERM; BIA-ALCL; RECONSTRUCTION;
D O I
10.1097/PRS.0000000000010195
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background:The association between textured implants and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is well established, but the risk of BIA-ALCL in patients with transient exposure to a textured tissue expander (TE) is not as well documented. The aim of this study was to assess the incidence and risk of BIA-ALCL in patients with temporary exposure to a textured TE with subsequent smooth implant placement. Methods:This single-institution retrospective cohort study included all female patients who underwent two-stage breast reconstruction with placement of a textured TE from 1995 to 2016 with subsequent exchange to a smooth permanent implant. Primary outcome of interest was development of BIA-ALCL. Patients with exposure to textured implants were excluded. Follow-up was determined by last documented visit. The authors calculated summary statistics for exposure time and follow-up intervals. Results:Overall, 3310 patients had temporary exposure to a textured TE with exchange to a smooth implant, totaling 5201 textured TEs. Average textured TE exposure time was 6.7 months (median, 5.8 months). Average follow-up was 6.8 years (median, 6.3 years), ranging from 3.7 months to 18 years. No cases of BIA-ALCL were identified. Conclusions:As no cases of BIA-ALCL were identified, the risk of BIA-ALCL with short exposure to textured TEs is likely lower than the risk from exposure to permanent textured implants. Although longer follow-up is needed, these results can help counsel patients with previous exposure to textured TEs who are concerned about their risk of BIA-ALCL and can contribute to discussions on potential continued utility of textured TEs.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [31] A Spectrum of Disease Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Associations
    Fracol, Megan E.
    Rodriguez, Megan M.
    Clemens, Mark W.
    CLINICS IN PLASTIC SURGERY, 2023, 50 (02) : 249 - 257
  • [32] Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
    Ha, Michael
    Ngaage, Ledibabari M.
    Zhu, Kevin
    Hricz, Nicholas
    Slezak, Sheri
    Rasko, Yvonne M.
    AESTHETIC SURGERY JOURNAL, 2021, 41 (12) : NP1943 - NP1949
  • [33] Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients
    Adrada, Beatriz E.
    Miranda, Roberto N.
    Rauch, Gaiane Margishvili
    Arribas, Elsa
    Kanagal-Shamanna, Rashmi
    Clemens, Mark W.
    Fanale, Michelle
    Haideri, Nisreen
    Mustafa, Eid
    Larrinaga, John
    Reisman, Neal R.
    Jaso, Jesse
    You, M. James
    Young, Ken H.
    Medeiros, L. Jeffrey
    Yang, Wei
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 1 - 14
  • [34] Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support
    Serena Oliveri
    Giulia Ongaro
    Ilaria Durosini
    Giuseppe Curigliano
    Gabriella Pravettoni
    Breast Cancer Research and Treatment, 2020, 181 : 221 - 224
  • [35] Online Patient Resources for Breast Implant-Associated Anaplastic Large Cell Lymphoma A Readability Analysis
    Cheah, Michael A.
    Sarmiento, Samuel
    Bernatowicz, Elizabeth
    Rosson, Gedge D.
    Cooney, Carisa M.
    ANNALS OF PLASTIC SURGERY, 2020, 84 (04) : 346 - 350
  • [36] FDG PET/CT and Ultrasound Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Pandika, Veska
    Covington, Matthew F.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 68 - 73
  • [37] Sarcoidosis Presenting as Late Seroma Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Ibarra, Gorka
    Vallejo, Alfonso
    Rivera, Andres
    Fernandez-Ibarburu, Borja
    Garcia-Ruano, Angela
    ANNALS OF PLASTIC SURGERY, 2021, 87 (04) : 415 - 420
  • [38] Breast Implant-Associated Anaplastic Large Cell Lymphoma Awareness: An Analysis of the Responses to an Institutional Campaign and Global Recall
    Mason, Madeleine M.
    Kuruoglu, Doga
    Zheng, Eugene E.
    Kerivan, Lauren T.
    Nguyen, Minh-Doan T.
    ANNALS OF PLASTIC SURGERY, 2023, 91 (05) : 529 - 533
  • [39] Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies
    Naga, Hani, I
    Mellia, Joseph A.
    Basta, Marten N.
    Morris, Martin P.
    Christopher, Adrienne N.
    Campbell, Frank M.
    Sommers, Katie
    Levinson, Howard
    Nelson, Jonas A.
    Fischer, John P.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (04) : 762 - 769
  • [40] Breast implant-associated anaplastic large cell lymphoma in Romania: First case series of all documented cases
    Mares, Theodor
    Ionescu, Radu
    Dima, Daniel
    Sorotos, Michail
    di Pompeo, Fabio Santanelli
    Jecan, Cristian Radu
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2024, 99 : 602 - 607